Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Gruppo Oncologico Dell'Italia Meridionale
Sponsor

Gruppo Oncologico Dell'Italia Meridionale

Italy Viale John Fitzgerald Kennedy 50, 70124 Bari, Italy

About the sponsor

The sponsor’s clinical research is centered on metastatic colorectal cancer, with a strong focus on treatment strategies for patients with advanced disease and prior treatment exposure.

  • RAS/BRAF wild-type disease
  • Second-line and later-line treatment
  • Biomarker-selected patient populations

Its studies address molecularly defined subgroups within metastatic colorectal cancer, reflecting a sustained interest in precision-oriented oncology care.

About Specializations

Gruppo Oncologico Dell'Italia Meridionale runs clinical trials in conditions such as Colorectal cancer metastatic, Colorectal cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Colorectal cancer metastatic

Recruiting

Comparing irinotecan plus cetuximab with trifluridine and tipiracil plus bevacizumab for patients with metastatic colorectal cancer as third line treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Trifluridine
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale

Colorectal cancer metastatic

Recruiting

Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale

Colorectal cancer

Recruiting

Study on Avelumab and Cetuximab for Patients with Metastatic Colorectal Cancer Who Have Previously Received Treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale

Colorectal cancer metastatic

Not recruiting

Study on Cetuximab-Based Treatment for Metastatic Colorectal Cancer in Patients with RAS/BRAF Wild Type Tumors

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Trifluridine
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.